• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210

1-(3-Aminopropyl)-6-methylpyridin-2(1H)-one hydrochloride: A Comprehensive Overview

The compound 1-(3-Aminopropyl)-6-methylpyridin-2(1H)-one hydrochloride, identified by the CAS number 1176063-22-1, is a significant molecule in the field of organic chemistry and pharmacology. This compound has garnered attention due to its unique structural properties and potential applications in drug development. The molecule combines a pyridinone ring with an aminopropyl group and a methyl substituent, making it a versatile building block for various chemical reactions and biological studies.

Recent studies have highlighted the importance of pyridinone derivatives in medicinal chemistry, particularly their role as scaffolds for bioactive compounds. The presence of the pyridinone ring in 1-(3-Aminopropyl)-6-methylpyridin-2(1H)-one hydrochloride contributes to its ability to interact with biological targets, such as enzymes and receptors. This interaction potential makes it a promising candidate for the development of new therapeutic agents.

The synthesis of this compound involves a multi-step process, including nucleophilic substitution and cyclization reactions. Researchers have optimized these steps to achieve high yields and purity, ensuring that the compound is suitable for both laboratory studies and potential industrial applications. The use of advanced chromatographic techniques has further enhanced the characterization of this compound, providing detailed insights into its physical and chemical properties.

In terms of biological activity, 1-(3-Aminopropyl)-6-methylpyridin-2(1H)-one hydrochloride has shown promising results in preliminary assays targeting various disease states. For instance, studies have demonstrated its potential as an inhibitor of key enzymes involved in neurodegenerative diseases, such as acetylcholinesterase. Additionally, its ability to modulate ion channels has opened avenues for research in cardiovascular drug discovery.

The structural flexibility of this compound allows for further functionalization, enabling researchers to explore its potential in other therapeutic areas. For example, the aminopropyl group can serve as a site for conjugation with other bioactive molecules, creating hybrid compounds with enhanced pharmacokinetic profiles. This adaptability underscores the importance of 1-(3-Aminopropyl)-6-methylpyridin-2(1H)-one hydrochloride as a valuable tool in modern drug design.

From an environmental perspective, the synthesis and handling of this compound adhere to strict safety protocols to minimize ecological impact. Its stability under various storage conditions ensures that it can be transported and stored without degradation, making it suitable for large-scale production if required.

In conclusion, 1-(3-Aminopropyl)-6-methylpyridin-2(1H)-one hydrochloride represents a significant advancement in organic chemistry, offering both structural diversity and functional versatility. As research continues to uncover its full potential, this compound is poised to play a pivotal role in the development of innovative therapeutic solutions across multiple disease areas.

• 19006-63-4(1-Propyl-2(1H)-pyridinone)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)